Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 09:35 am Sale | 13G | AGENUS INC AGEN | RTW INVESTMENTS LP | 5,868,315 2.3% | -6,996,362 (-54.38%) | View |
2022-02-14 09:33 am Purchase | 13G | Science 37 Holdings Inc. SNCE | RTW INVESTMENTS LP | 3,975,000 3.5% | 3,975,000 (New Position) | View |
2022-02-14 09:32 am Sale | 13G | VINCERX PHARMA, INC VINC | RTW INVESTMENTS LP | 741,236 3.5% | -8,764 (-1.17%) | View |
2022-02-14 09:31 am Purchase | 13G | C4 THERAPEUTICS INC CCCC | RTW INVESTMENTS LP | 2,494,965 5.1% | 2,494,965 (New Position) | View |
2022-02-14 09:29 am Purchase | 13G | TENAYA THERAPEUTICS INC TNYA | RTW INVESTMENTS LP | 2,458,750 6% | 2,458,750 (New Position) | View |
2022-02-14 09:26 am Purchase | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | RTW INVESTMENTS LP | 2,590,932 9.3% | 193,554 (+8.07%) | View |
2022-02-14 08:58 am Purchase | 13G | CytomX Therapeutics Inc. CTMX | RTW INVESTMENTS LP | 6,029,700 9.2% | 161,374 (+2.75%) | View |
2022-02-14 08:56 am Sale | 13G | EXAGEN INC. XGN | RTW INVESTMENTS LP | 821,414 5.1% | -428,717 (-34.29%) | View |
2022-02-14 08:55 am Purchase | 13G | Jounce Therapeutics Inc. JNCE | RTW INVESTMENTS LP | 2,863,198 5.6% | 2,863,198 (New Position) | View |
2022-02-14 08:53 am Purchase | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | RTW INVESTMENTS LP | 16,250,000 6.8% | 16,250,000 (New Position) | View |
2022-02-14 08:51 am Purchase | 13G | PYXIS ONCOLOGY INC PYXS | RTW INVESTMENTS LP | 2,120,760 6.5% | 2,120,760 (New Position) | View |
2022-02-14 08:50 am Purchase | 13G | MACROGENICS INC MGNX | RTW INVESTMENTS LP | 3,975,554 6.5% | 3,975,554 (New Position) | View |
2022-02-14 08:48 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 7,554,817 7.7% | 327,453 (+4.53%) | View |
2022-02-14 08:47 am Purchase | 13G | CUTERA INC CUTR | RTW INVESTMENTS LP | 1,397,063 7.8% | 21,400 (+1.56%) | View |
2022-02-14 08:46 am Sale | 13G | ESSA Pharma Inc. EPIX | RTW INVESTMENTS LP | 2,637,192 6% | -391,527 (-12.93%) | View |
2022-02-14 08:45 am Purchase | 13G | Oyster Point Pharma Inc. OYST | RTW INVESTMENTS LP | 2,058,504 7.9% | 132,910 (+6.90%) | View |
2022-02-14 08:44 am Sale | 13G | Clearside Biomedical Inc. CLSD | RTW INVESTMENTS LP | 3,806,018 6.4% | -152,112 (-3.84%) | View |
2022-02-14 08:43 am Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RTW INVESTMENTS LP | 2,186,324 7.9% | 673,651 (+44.53%) | View |
2022-02-14 08:43 am Purchase | 13G | IDEAYA Biosciences Inc. IDYA | RTW INVESTMENTS LP | 2,520,076 6.5% | 423,233 (+20.18%) | View |
2022-02-14 08:41 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,921,579 8.4% | 498,724 (+14.57%) | View |